太龙药业：获准注册8亿元超短期融资券

Core Viewpoint - Tailong Pharmaceutical (600222.SH) has received a registration notice from the China Interbank Market Dealers Association for its technology innovation bonds, indicating a strategic move to raise funds through short-term financing [1] Group 1: Company Announcement - The company announced the acceptance of its registration for technology innovation bonds, specifically ultra-short-term financing bills [1] - The registered amount for the bonds is set at 800 million yuan, with the registration validity period being two years from the date of the notice [1] - China Minsheng Banking Corp. and Shanghai Pudong Development Bank are appointed as the joint lead underwriters for this bond issuance [1]